V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320006919 | 320003234 | 1.73 | 105.8 | null | 2018-06-19 | 2018-07-17 | Carboplatin + Liposomal Doxorubicin | 2 | N | 320014198 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006920 | 320007033 | 1.67 | 54.5 | Palliative (P) | 2019-03-21 | 2019-03-25 | CISPLATIN + FLUOROURACIL | 02 | N | 320014251 | CISPLATIN + FLUOROURACIL |
| 320006921 | 320003245 | 1.47 | 106.8 | Palliative (P) | 2019-05-05 | 2019-05-07 | Carboplatin + Liposomal Doxorubicin | N | N | 320014262 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006922 | 320003250 | 1.61 | 71.2 | Palliative (P) | 2018-11-03 | 2018-11-05 | Trial Unspecified | null | null | 320014289 | TRIAL |
| 320006923 | 320003254 | 1.6 | 93 | Palliative (P) | 2019-03-11 | 2019-04-17 | Trial Unspecified | N | N | 320014301 | TRIAL |
| 320006924 | 320003256 | 1.75 | 73 | Palliative (P) | 2015-12-25 | 2015-12-27 | GemCarbo Days 1+8 | N | N | 320014317 | GEMCARBO |
| 320006925 | 320005484 | 1.5 | 55 | Palliative (P) | 2017-11-25 | 2018-12-01 | Cetuximab 7 day (>Cycle 2) | 2 | N | 320014334 | CETUXIMAB |
| 320006926 | 320003259 | 1.66 | 51.4 | Palliative (P) | null | 2015-02-18 | GemCarbo Days 1+8 | Y | N | 320014339 | GEMCARBO |
| 320006927 | 320003261 | 1.73 | 107 | Palliative (P) | 2015-12-12 | 2015-12-12 | Cetuximab 7 day (>Cycle 2) | N | N | 320014364 | CETUXIMAB |
| 320006928 | 320003265 | null | 86 | Palliative (P) | 2017-06-30 | 2017-07-01 | Carboplatin + Liposomal Doxorubicin | 02 | Y | 320014377 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006929 | 320005489 | 1.7 | 121.95 | Palliative (P) | 2018-03-08 | 2018-03-08 | Cisplatin | 2 | N | 320014385 | CISPLATIN |
| 320006930 | 320003273 | 1.59 | 96.6 | Palliative (P) | 2019-08-16 | 2019-08-24 | Liposomal Doxorubicin (Caelyx) | null | null | 320014411 | LIPOSOMAL DOXORUBICIN |
| 320006931 | 320003275 | null | 80 | Palliative (P) | 2016-10-28 | 2016-11-01 | Cetuximab 7 day (>Cycle 2) | Y | N | 320014420 | CETUXIMAB |
| 320006932 | 320003277 | 1.52 | null | Adjuvant (A) | 2016-05-10 | 2016-09-16 | null | 2 | N | 320014421 | NOT MATCHED |
| 320006933 | 320003283 | 1.6 | 62 | Palliative (P) | 2012-09-29 | 2015-07-09 | GemCarbo Days 1+8 | N | N | 320014450 | GEMCARBO |
| 320006934 | 320003289 | 1.6 | 72.4 | Palliative (P) | 2016-10-19 | 2016-11-13 | Liposomal Doxorubicin 50mg/m2 | N | N | 320014484 | LIPOSOMAL DOXORUBICIN |
| 320006935 | 320005502 | 1.7 | 80.2 | Adjuvant (A) | 2016-12-09 | 2016-12-14 | Cisplatin 100 + RT(H&N) 1 day | 1 | N | 320014561 | CISPLATIN + RT |
| 320006936 | 320003304 | 1.54 | 60.2 | Palliative (P) | 2014-08-30 | 2014-09-20 | Olaratumab | 1 | N | 320014585 | NOT MATCHED |
| 320006937 | 320003310 | 1.53 | 86 | Palliative (P) | 2016-03-24 | 2016-03-24 | Liposomal Doxorubicin (Caelyx) | 2 | N | 320014590 | LIPOSOMAL DOXORUBICIN |
| 320006938 | 320003313 | 1.63 | 60.4 | Palliative (P) | 2019-04-23 | 2019-06-11 | CISPLATIN + FLUOROURACIL | N | null | 320014592 | CISPLATIN + FLUOROURACIL |
| 320006939 | 320003331 | 1.24 | 72 | Adjuvant (A) | 2015-08-15 | 2017-05-27 | Carboplatin + Liposomal Doxorubicin | N | N | 320014715 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006940 | 320003335 | 1.51 | 52.35 | Palliative (P) | 2016-05-02 | 2016-05-20 | CARBOPLATIN + GEMCITABINE | N | N | 320014723 | GEMCARBO |
| 320006941 | 320005518 | 1.87 | null | Palliative (P) | 2014-12-16 | 2015-02-08 | Trial Unspecified | 02 | N | 320014758 | TRIAL |
| 320006942 | 320003347 | 1.8 | 58.5 | Palliative (P) | 2015-08-01 | 2015-08-06 | CISPLATIN + FLUOROURACIL | 2 | N | 320014785 | CISPLATIN + FLUOROURACIL |
| 320006943 | 320003361 | 1.6 | 96.6 | null | 2018-01-16 | 2018-01-30 | Trial Unspecified | N | N | 320014927 | TRIAL |
| 320006944 | 320007457 | 1.62 | 50.6 | Curative (C) | 2017-09-10 | 2017-09-16 | Cisplatin + Radiotherapy | 99 | N | 320014955 | CISPLATIN + RT |
| 320006945 | 320003364 | 1.8 | 75.3 | Palliative (P) | 2019-07-09 | 2019-07-16 | GemCarbo Days 1+8 | 02 | N | 320014965 | GEMCARBO |
| 320006946 | 320003369 | 0 | 70.5 | Adjuvant (A) | 2017-09-17 | 2017-09-19 | Liposomal Doxorubicin (Caelyx) | 2 | Y | 320014992 | LIPOSOMAL DOXORUBICIN |
| 320006947 | 320003373 | 1.64 | null | Curative (C) | 2015-10-23 | 2015-11-02 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 320014998 | CISPLATIN + RT |
| 320006948 | 320003378 | 1.8 | null | Adjuvant (A) | 2014-11-19 | 2014-11-26 | GemCarbo Days 1+8 | N | N | 320015033 | GEMCARBO |
| 320006949 | 320007052 | 1.72 | 100.9 | Palliative (P) | 2017-05-10 | 2017-05-10 | LUX TRIAL | 02 | N | 320015086 | TRIAL |
| 320006950 | 320003398 | 1.87 | 25.4 | Palliative (P) | 2016-12-30 | 2017-01-16 | CISPLATIN + FLUOROURACIL | Y | null | 320015145 | CISPLATIN + FLUOROURACIL |
| 320006951 | 320006571 | 1.74 | 74.6 | Palliative (P) | 2017-03-05 | 2017-03-06 | CETUXIMAB | 02 | N | 320015153 | CETUXIMAB |
| 320006952 | 320003405 | null | 88.6 | Palliative (P) | 2016-08-06 | 2018-09-13 | Liposomal Doxorubicin (Caelyx) | N | null | 320015183 | LIPOSOMAL DOXORUBICIN |
| 320006953 | 320003418 | 1.79 | 62 | Palliative (P) | 2014-01-21 | 2014-01-30 | Liposomal Doxorubicin 50mg/m2 | N | Y | 320015241 | LIPOSOMAL DOXORUBICIN |
| 320006954 | 320003421 | 1.63 | 108.5 | Palliative (P) | 2013-10-16 | 2015-09-24 | Liposomal Doxorubicin 50mg/m2 | 2 | N | 320015242 | LIPOSOMAL DOXORUBICIN |
| 320006955 | 320007279 | 1.87 | 103 | null | 2017-07-08 | 2017-07-21 | Trial Unspecified | N | N | 320015262 | TRIAL |
| 320006956 | 320005555 | 1.62 | 0 | Palliative (P) | 2017-12-06 | 2017-12-06 | Trial Unspecified | N | Y | 320015290 | TRIAL |
| 320006957 | 320003430 | 1.8 | null | Curative (C) | 2017-08-07 | 2017-09-13 | Cisplatin + Radiotherapy | N | N | 320015306 | CISPLATIN + RT |
| 320006958 | 320003432 | 1.64 | 54.5 | Not known (9) | 2018-10-02 | 2018-12-25 | Cisplatin | 02 | Y | 320015317 | CISPLATIN |
| 320006959 | 320007280 | 1.66 | 55.4 | Palliative (P) | 2018-11-19 | 2018-11-19 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | 320015321 | CISPLATIN + FLUOROURACIL |
| 320006960 | 320003434 | 1.84 | 105.1 | Palliative (P) | 2014-04-21 | 2014-04-23 | Liposomal Doxorubicin 40mg/m2 | N | N | 320015336 | LIPOSOMAL DOXORUBICIN |
| 320006961 | 320005564 | null | null | Palliative (P) | 2016-02-26 | 2016-03-02 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 320015353 | LIPOSOMAL DOXORUBICIN |
| 320006962 | 320005565 | 1.79 | 77.4 | Palliative (P) | 2018-02-27 | 2018-03-03 | GemCarbo Days 1+8 | N | Y | 320015363 | GEMCARBO |
| 320006963 | 320003450 | 1.8 | 83 | Palliative (P) | 2018-11-30 | 2018-11-30 | Cisplatin +Fluorouracil (3 wk) | N | N | 320015393 | CISPLATIN + FLUOROURACIL |
| 320006964 | 320003455 | 1.7 | 88.6 | Curative (C) | 2018-10-30 | 2018-10-31 | Carboplatin + Liposomal Doxorubicin | 2 | N | 320015411 | CARBOPLATIN + LIPOSOMAL DOX |
| 320006965 | 320003463 | 1.69 | 84.199 | Curative (C) | 2017-05-26 | 2017-07-12 | Cisplatin + Radiotherapy | Y | N | 320015469 | CISPLATIN + RT |
| 320006966 | 320003466 | null | 67.7 | Curative (C) | 2018-01-12 | 2018-01-27 | Trial Unspecified | N | N | 320015477 | TRIAL |
| 320006967 | 320003468 | 1.9 | null | Palliative (P) | 2016-06-06 | 2016-06-15 | Cisplatin | N | Y | 320015491 | CISPLATIN |
| 320006968 | 320003473 | null | 69 | Palliative (P) | 2016-02-15 | 2016-02-15 | GemCarbo Days 1+8 | 02 | N | 320015567 | GEMCARBO |